MCA logo
MCA logo



AstraZeneca And Institute Kanser Negara Partner to Introduce AI Technology For Lung Screening

Vinod_Narayanan___Country_President__AstraZeneca_Malaysia__together_with_Dr__Puteri_Norliza Lung screening
In conjunction with Institut Kanser Negara’s (IKN) 10th anniversary, AstraZeneca announced its collaboration to accelerate digitalisation in healthcare by introducing Artificial Intelligence (AI) x-ray technology into early lung screening at government clinics and hospitals under the Projek Saringan Awal Paru-Paru (SAPU) programme. As a centre of excellence for cancer care in the country, IKN will be the first government institution in the country to implement this AI technology.

Sign Up or Log In as a healthcare professional to read the full article.

Share via

Also worth reading

People also read: